Modern approaches for perinatal management in thrombocytopenia during pregnancy


  • О.М. Naumchik SI «Institute of Pediatrics, Obstetrics and Gynecology named after academician O.M. Lukyanova of the NAMS of Ukraine», Kyiv, Ukraine
  • Iu.V. Davydova SI «Institute of Pediatrics, Obstetrics and Gynecology named after academician O.M. Lukyanova of the NAMS of Ukraine», Kyiv, Ukraine
  • A.Yu. Limanska SI «Institute of Pediatrics, Obstetrics and Gynecology named after academician O.M. Lukyanova of the NAMS of Ukraine», Kyiv, Ukraine



pregnancy, thrombocytopenia, immune thrombocytopenia, gestational thromocytopenia


The most common diseases of the blood system in pregnant women are anemia and thrombocytopenia (TP). There is a general tendency to significantly reducing of the number of platelets during pregnancy, starting from the first trimester with a minimum number of them during childbirth.

Purpose — to learn the features of motion of pregnancy, diagnostic and curative tactician at the thrombocytopenia during pregnancy.

The causes of TP during pregnancy are three groups of conditions — conditions for which TP is characteristic outside of pregnancy and conditions associated with pregnancy: gestational thrombocytopenia (GTP), pregnancy-specific complications, manifestations of diseases characterized by TP, with the chief reason among them — immune thrombocytopenia (ITP). The most common cause of TP during pregnancy is GTP, which, like ITP, is diagnose of exclusion that require differential diagnosis. The goal of treating TP during pregnancy is to achieve a safe platelet count that is different for each trimester, not target values. If the treatment of ITP is need lines of therapy with control of efficiency are consistently applied. Pregnant women with moderate and severe TP are a group of high perinatal risk, requiring careful differential diagnosis of the causes of TP, calculation of maternal and fetal risks, choice of tactics of such pregnancy, method and time of delivery, formation of postnatal care plan.

No conflict of interest was declared by the authors.


ACOG. (2019). Practice Bulletin No. 207: Thrombocytopenia in Pregnancy. Obstet Gynecol. 133: 181.

Davyidova YuV, Limanskaya AYu, Ogorodnik AO, Butenko LP, Bayder AK. (2017). Sovremennyie podhodyi k korrektsii trombotsitopenii vo vremya gestatsii i v poslerodovom periode. Zdorovia Ukrainy 21 storichchia. 11-12: 408-409.

George JN, McIntosh JJ. (2020, Apr). Thrombocytopenia in pregnancy. UpToDate.

Gernsheimer T, James AH, Stasi R. (2013). How I treat thrombocytopenia in pregnancy. Blood. 121 (1): 38-47.; PMid:23149846

Jamal S, Goel N, Mehta A, Ahuja M. (2017). Recurrent severe gestational thrombocytopenia in pregnancy: a case report. Int J Adv Med. 4: 1702-1705.

Kim BJ, Kim HS, Kim JH, Lee KY. (2017). Moderate to Severe Thrombocytopenia During Pregnancy: A Single Institutional Experience. Indian J Hematol Blood Transfus. 33 (4): 581-585.; PMid:29075073 PMCid:PMC5640537

Loustau V, Debouverie O, Canoui-Poitrine F, Baili L, Khellaf M et al. (2014). Effect of pregnancy on the course of immune thrombocytopenia: a retrospective study of 118 pregnancies in 82 women. Br J Haematol. 166 (6): 929-935.; PMid:24957165

Palta A, Dhiman P. (2016). Thrombocytopenia in pregnancy. J Obstet Gynaecol. 36 (2): 146-152.; PMid:26431056

Parnas M, Sheiner E, Shoham-Vardi I, Burstein E, Yermiahu T, Levi I, Holcberg G, Yerushalmi R. (2006). Moderate to severe thrombocytopenia during pregnancy. Eur J Obstet Gynecol Reprod Biol. 128 (1-2): 163-168.; PMid:16533554

Pavord S, Hunt B. (2010). The Obstetric Hematology Manual. Cambridge University Press.

Provan D, Arnold DM, Bussel JB, Chong BH, Cooper N et al. (2019). Updated international consensus report on the investigation and management of primary immune thrombocytopenia. Blood. 3 (22): 3780-3817.; PMid:31770441 PMCid:PMC6880896

Rajasekhar A, Gernsheimer T, Stasi R, James AH. (2013). 2013 Clinical Practice Guide on Thrombocytopenia in Pregnancy. Washington, DC: American Society of Hematology.

Ramadan MK, Hubeich M, Itani SE, Mogharbil A. (2016). Severe Gestational Thrombocytopenia: A Case Report and Brief Review of the Literature. Journal of Hematology. 5 (4): 142-150.

Reese JA, Peck JD, Deschamps DR, McIntosh JJ, Knudtson EJ et al. (2018). Platelet Counts during Pregnancy. N Engl J Med. 379: 32-43.; PMid:29972751 PMCid:PMC6049077

Reese JA, Peck JD, Yu Z, Scordino TA, Deschamps DR et al. (2019). Platelet sequestration and consumption in the placental intervillous space contribute to lower platelet counts during pregnancy. Am J Hematol. 94 (1): 8-11.; PMid:30328633 PMCid:PMC6447301

Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D et al. (2009, Mar 12). Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood. 113 (11): 2386-2393.; PMid:19005182

Sankaran S, Robinson SE. (2011). Immune thrombocytopenia and pregnancy. Obstet Med. 4 (4): 140-146.; PMid:27579112 PMCid:PMC4989643

Webert KE, Mittal R, Sigouin C, Heddle NM, Kelton JG. (2003). A retrospective 11-year analysis of obstetric patients with idiopathic thrombocytopenic purpura. Blood. 102: 4306-4311.; PMid:12947011